TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment

NCT02711813 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative reasons

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: TAB08
OTHER: Placebo

Sponsor

Theramab LLC